BIO-TECHNE Corp

TECH · Nasdaq · SIC 2836: Biological Products, (No Diagnostic Substances) · Market Cap: $8.6B · 3,100 employees
264
SEC Filings
$51.68
Close 2026-05-29
3,100
Employees

Business Summary

Bio-Techne Corporation is a life sciences company that develops and manufactures biological reagents, instruments, and clinical controls. The company provides proteins, antibodies, assays, and analytical instruments used in research and clinical diagnostics. Its products serve academic researchers, biopharmaceutical companies, and clinical laboratories globally across its multiple business segments.

Latest Stock Quote

TECH 2026-05-29 $51.68 O:$50.61 H:$52.13 L:$50.42 Vol:2.9M VWAP:$51.5675
origin leaf: 2e5c84e56e6d52bd9a390304b366bc4531a983cec7312e07d3e72228221c2817

Next Earnings

Q2 FY2026 — expected 2026-08-06

Annual Reports (10-K)

FiledPeriodAccessionSourceFull Text
2025-08-222025-06-300001558370-25-011716EDGAR59K words
2024-08-222024-06-300001558370-24-012430EDGAR
2023-08-232023-06-300001558370-23-015226EDGAR
2022-08-242022-06-300001558370-22-013935EDGAR
2021-08-252021-06-300001437749-21-020980EDGAR
2020-08-262020-06-300001437749-20-018754EDGAR
2019-08-282019-06-300001437749-19-017565EDGAR
2018-08-272018-06-300001437749-18-016190EDGAR
2017-09-072017-06-300001437749-17-015711EDGAR
2016-08-292016-06-300001437749-16-038182EDGAR

Quarterly Reports (10-Q)

FiledPeriodAccessionSourceFull Text
2026-02-042025-12-310001104659-26-010335EDGAR23K words
2025-11-052025-09-300001104659-25-107053EDGAR
2025-05-082025-03-310001558370-25-006990EDGAR
2025-02-062024-12-310001558370-25-000689EDGAR
2024-11-052024-09-300001558370-24-014439EDGAR
2024-05-062024-03-310001558370-24-006803EDGAR
2024-02-072023-12-310001558370-24-000862EDGAR
2023-11-072023-09-300001558370-23-018018EDGAR
2023-05-082023-03-310001558370-23-008540EDGAR
2023-02-072022-12-310001558370-23-000979EDGAR
2022-11-072022-09-300001558370-22-016640EDGAR
2022-05-092022-03-310001558370-22-007844EDGAR

Recent Current Reports (8-K)

FiledAccessionSourceFull Text
2026-02-110001104659-26-013412EDGAR10K words
2026-02-040001104659-26-009994EDGAR
2025-11-050001104659-25-106631EDGAR
2025-08-060001558370-25-010393EDGAR
2025-05-070001558370-25-006594EDGAR
2025-05-060001558370-25-006512EDGAR
2025-03-040001558370-25-002177EDGAR
2025-02-050001558370-25-000639EDGAR
2024-11-050001558370-24-014442EDGAR
2024-10-300001558370-24-013879EDGAR

264 total filings indexed. 232 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR

Sector Peers

FDMT — 4D Molecular Therapeutics, Inc. APTN — ADAPTIN BIO, INC. ADMA — ADMA BIOLOGICS, INC. AGEN — AGENUS INC AIM — AIM ImmunoTech Inc. AMGN — AMGEN INC AVXL — ANAVEX LIFE SCIENCES CORP. ABPO — Abpro Holdings, Inc.

Tags

life-sciences-research biopharmaceuticals clinical-diagnostics academic-research

Company Identity

CIK0000842023
TickerTECH
ExchangeNasdaq
SIC2836: Biological Products, (No Diagnostic Substances)
IncorporatedMN
Websitehttps://www.bio-techne.com
Listed1989-05-08

Get More Data

This is the free public profile. For structured JSON with full provenance chain, use the API:

JSON Profile Stock Quote AI Readiness Report
Origin Provenance
page leaf: b4a080577b73dfb2c5fcf057aea6c37fd567fa224ee7cb4bef26ee77f69757c7
parent: c4642b65758e73128a22b2f2889751168f6c5e4ff628570cf5b9c9ff8379029f
content hash: 96e35376b74c4a0fa6a24b6304dd9b302dfec016f33fadeb4de15984b7149952
signed: 2026-06-02T19:02:49.184Z
sources: 23 verified data leaves
chain: SEC.gov PEM → origin.rootz.global extraction → this page
verify: sha256(content_hash + parent + timestamp) = leaf